Literature DB >> 20505939

Bleeding disorders and reduced bone density.

Hassan Mansouritorghabeh1, Zahra Rezaieyazdi.   

Abstract

In recent decays, quality of life and life expectancy of individuals with severe haemophilia A and B have been improved by better quality in treatment and more availability of blood coagulation products. Recently, new concerns have emerged in current groups such as auto-antibody inhibitors to coagulation factors and reduced bone density (RBD). RBD in bleeding disorders is becoming an escalating burden worldwide due to an increased in life expectancy and also in the ageing population with bleeding disorders. Here, we review published papers on bone mineral density of individuals with haemophilia A & B, a rare bleeding disorder entitled combined factor V and VIII deficiency and other rare bleeding disorders. It seems in individuals with bleeding disorders preventive measures including early detection, treatment and adequate physical activity, encouragement to be active in sports and finally anti-osteoporotic therapy must be done.

Entities:  

Mesh:

Year:  2010        PMID: 20505939     DOI: 10.1007/s00296-010-1534-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  34 in total

Review 1.  Bone mass acquisition in healthy children.

Authors:  J H Davies; B A J Evans; J W Gregory
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

2.  The hematological etiology of osteoporosis.

Authors:  Olga Gurevitch; Shimon Slavin
Journal:  Med Hypotheses       Date:  2006-06-23       Impact factor: 1.538

3.  Reduced bone density in individuals with combined factor V and VIII deficiency.

Authors:  H Mansouritorghabeh; Z Rezaieyazdi; J Rezai
Journal:  Haemophilia       Date:  2007-05       Impact factor: 4.287

4.  Osteoporosis in haemophilia - an underestimated comorbidity?

Authors:  T A Wallny; D T Scholz; J Oldenburg; C Nicolay; S Ezziddin; P H Pennekamp; B Stoffel-Wagner; C N Kraft
Journal:  Haemophilia       Date:  2007-01       Impact factor: 4.287

5.  Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia.

Authors:  G Gerstner; M L Damiano; A Tom; C Worman; W Schultz; M Recht; A T Stopeck
Journal:  Haemophilia       Date:  2009-02-01       Impact factor: 4.287

6.  Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study.

Authors:  S J Gallacher; C Deighan; A M Wallace; R A Cowan; W D Fraser; J A Fenner; G D Lowe; I T Boyle
Journal:  Q J Med       Date:  1994-03

7.  Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Charoula Xirakia; Konstantinos Varvagiannis; Georgios Boutsikas; Antonios Bilalis; Efstathios Kastritis; Athanasios Papatheodorou; Evangelos Terpos
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

Review 8.  New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.

Authors:  Ersi Voskaridou; Evangelos Terpos
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

9.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

10.  Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.

Authors:  Olga Katsarou; Evangelos Terpos; Pantelis Chatzismalis; Stefanos Provelengios; Theophanis Adraktas; Dimitrios Hadjidakis; Anna Kouramba; Anastasia Karafoulidou
Journal:  Ann Hematol       Date:  2009-06-02       Impact factor: 3.673

View more
  3 in total

Review 1.  Clinical and laboratory approaches to hemophilia a.

Authors:  Hassan Mansouritorghabeh
Journal:  Iran J Med Sci       Date:  2015-05

Review 2.  Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  J Bone Metab       Date:  2017-11-30

3.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.